Tag Archives: European Union

And What Exactly is a Stakeholder?

Pharma’s uncritical use of the word ‘stakeholder’ has increased to the point where it can refer to almost anyone connected to the industry. But this can have serious consequences, warns Reflector. Like it or not (and frankly, I don’t), stakeholders are here to stay in European pharmaceutical affairs. Don’t get me wrong. I’ve no objection to [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , , | 1 Comment

Europe: Resisting the Anticompetitive Crusade

It’s been another rocky few weeks for pharma in Europe. Particularly for big brand name companies. But necessity is proving the mother of invention, says Pharm Exec’s Brussels correspondent, Reflector. AstraZeneca suffered a serious setback at the start of July when the European General Court ruled that it had illegally prevented generic competition. The case dates [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

HTA Concerns From European Drug Agency

The EMA’s Thomas Lönngren has gone public with his disquiet over organizations such as NICE. But pharma still needs more allies in fighting what it sees as the failings of the health technology assessment bodies, says Pharm Exec Europe’s Brussels correspondent, Reflector. Europe’s pharmaceutical firms were never very keen on Britain’s influential National Institute for Health [...]
Posted in Europe, Global, Guest Blog, Regulatory, Safety, Strategy | Also tagged , , , | Leave a comment

Nothing is Rotten in the State of Denmark

Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent. Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defence policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast [...]
Posted in Europe, Global, Guest Blog, Regulatory | Also tagged , , , , , , | Leave a comment

Europe: Of Apes and Ombudsmen

Guest blog by Reflector, Pharm Exec Europe’s Brussels correspondent. This column has frequently drawn attention to the complexities of getting anything done in Europe. A brilliant researcher can explore visionary horizons, an ambitious entrepreneur can offer a package of goods or services of inestimable value, but the degree of control and regulation becomes more intense [...]
Posted in Europe, Global, Regulatory | Also tagged , , , , | Leave a comment